Striatal DOPAC elevation predicts antipsychotic efficacy of metoclopramide.
D015102:3,4-Dihydroxyphenylacetic Acid / Q000378:metabolism*; D000818:Animals; D002746:Chlorpromazine / Q000494:pharmacology; D003342:Corpus Striatum / Q000187:drug effects / Q000378:metabolism*; D004305:Dose-Response Relationship, Drug; D007700:Kinetics; D008297:Male; D008787:Metoclopramide / Q000494:pharmacology*; D009830:Olfactory Bulb / Q000187:drug effects / Q000378:metabolism; D010648:Phenylacetates / Q000378:metabolism*; D011619:Psychotropic Drugs; D051381:Rats
D010648:Phenylacetates; D011619:Psychotropic Drugs; D015102:3,4-Dihydroxyphenylacetic Acid; D008787:Metoclopramide; D002746:Chlorpromazine